Coagulation, Bradykinin, Polyphosphates, and Angioedema
Type
article
Field-Weighted Citation Impact
6.50
Funders
Ionis Pharmaceuticals
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article
Patient‐Reported Outcomes in the Phase III OASIS‐HAE Study of Donidalorsen for Hereditary Angioedema
Danny M. Cohn, Sabrina Treadwell, Marc A. Riedl, Aaron Yarlas et al.
Citations
4 citations
Journal
Allergy
Topics
Coagulation, Bradykinin, Polyphosphates, and Angioedema
Field-Weighted Citation Impact (FWCI)
6.50
article
Patient‐Reported Outcomes in the Phase III OASIS‐HAE Study of Donidalorsen for Hereditary Angioedema
Danny M. Cohn, Sabrina Treadwell, Marc A. Riedl, Aaron Yarlas, Ken B. Newman, Sophie X. Wang, Laura Bordone
article en
4 citations
Abstract
No abstract available for this paper.
Publication Tag
AllergyVol. 80(8)
Institutions
Ionis Pharmaceuticals (United States) (US), University of California San Diego (US), Amsterdam University Medical Centers (NL), University of Amsterdam (NL)
Funders
Ionis Pharmaceuticals
Sustainable Development Goals
Decent work and economic growth
OpenAlex Percentile
Openalex Percentile: Top 4%
Topics
Coagulation, Bradykinin, Polyphosphates, and Angioedema